台灣泌尿科醫學會E-School

台灣泌尿科醫學會E-School

MP02-8: Comparation between penoscrotal approach with perineal approach for artificial sphincter implantation in male urinary incontinence_江品葭

2021-03-25 • 觀看: 6 • 回應: 0 • pdf
MP02-7: Increased cardiovascular risk after androgen deprivation therapies among newly diagnosed prostate cancer patients_謝享宸

2021-03-25 • 觀看: 4 • 回應: 0 • pdf
MP02-6: Nivolumab (NIVO) in pretreated patients with metastatic renal cell carcinoma (mRCC), a single hospital experience_倪雪雰

2021-03-25 • 觀看: 7 • 回應: 0 • pdf
MP02-5: Immune checkpoint inhibitors (ICIs) in end-stage renal disease (ESRD) patients with metastatic urothelial carcinoma (mUC)_黃英哲

2021-03-25 • 觀看: 6 • 回應: 0 • pdf
MP02-4: Metastatic urothelial carcinoma patients treated with immune checkpoint inhibitor based immunotherapy_陳韋辰

2021-03-25 • 觀看: 4 • 回應: 0 • pdf
MP02-3: Preoperative monocyte-to-lymphocyte ratio as a non-invasive diagnostic tool for prediction of renal cell carcinoma and oncocytoma in patients with renal tumor_林于巧

2021-03-25 • 觀看: 4 • 回應: 0 • pdf
MP02-2: Detection of circulating tumor cells in patients with penile squamous cell carcinoma: A preliminary study_江佩璋

2021-03-25 • 觀看: 3 • 回應: 0 • pdf
MP02-1: Outcome of robotic radical prostatectomy for locally advanced prostate cancer (≥ pT3 or N1)_李柏毅

2021-03-25 • 觀看: 10 • 回應: 0 • pdf
MP01-8: Combination of trans-perineal MRI– ultrasound fusion and template-guided mapping biopsy for prostate cancer diagnosis_胡蔚祥

2021-03-25 • 觀看: 14 • 回應: 0 • pdf
MP01-7: The role of PD-L1 and Ki-67 in upper tract urothelial carcinoma_蔡牧堯

2021-03-25 • 觀看: 6 • 回應: 0 • pdf
MP01-6: Perioperative and long-term oncological outcomes of patients with muscle invasive bladder cancer who underwent radical cystectomy: A single-center experience_曾文歆

2021-03-25 • 觀看: 7 • 回應: 0 • pdf
MP01-5: Combination of prostate health index with mpMRI for better assessment of true tumor boundary in prostate cancer_李宗叡

2021-03-25 • 觀看: 6 • 回應: 0 • pdf

Prev
509
510
511
512
513
514
515
516
517
518
Next
/ 1052